IM Cannabis Corp (IMCC)
NASDAQ:IMCC
Want to see IMCC full AI Analyst Report?
IMCC Stock Chart & Stats
$1.44
-$0.13(-4.96%)
At close: 4:00 PM EST
$1.44
-$0.13(-4.96%)
Day’s Range― - ―
52-Week Range$0.22 - $7.12
Previous Close$2.49
Volume28.72K
Average Volume (3M)72.27K
Market Cap
$1.79M
Enterprise Value$32.03M
Total Cash (Recent Filing)$1.15M
Total Debt (Recent Filing)$14.95M
Price to Earnings (P/E)―
Beta1.35
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.51
Shares Outstanding6,223,323
10 Day Avg. Volume74,089
30 Day Avg. Volume72,265
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-9.42
Price to Sales (P/S)0.15
P/FCF Ratio1.72
Enterprise Value/Market Cap17.87
Enterprise Value/Revenue0.73
Enterprise Value/Gross Profit4.42
Enterprise Value/Ebitda-6.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.32
Revenue Forecast (FY)$62.75M
Bulls Say, Bears Say
Bulls Say
Strong German Market PositionIM Cannabis's EU‑GMP‑backed platform and rapid German sales growth provide durable access to the largest regulated EU medical cannabis market. High German share (>two‑thirds) and scale create distribution leverage, regulatory credibility, and potential margin stability as regulations remain supportive.
Integrated Distribution And Retail ModelVertical integration across cultivation, processing, distribution, retail pharmacies and online channels strengthens control over supply and margin capture. This multi‑channel model plus data‑driven patient insights enhances resilience to single‑channel shocks and supports long‑term customer retention and product rollout.
Proven Ability To Generate Positive Operating Cash FlowAchieving positive operating and free cash flow in 2025 demonstrates the business can be cash‑generative at scale when cost discipline and German growth align. This indicates operational leverage potential and that management can convert revenue into cash under the right conditions, improving funding optionality.
Bears Say
Negative Shareholders' EquityNegative equity materially reduces financial flexibility and distorts leverage metrics, increasing refinancing and covenant risk. With ~ $15M of debt and equity erosion, the company may face higher financing costs, restricted credit access, and greater likelihood of dilutive capital raises absent sustained profitability.
Return To Cash Burn (TTM)The switch from 2025 positive cash flow to TTM cash burn shows cash generation is inconsistent. Persistent negative OCF/FCF undermines liquidity planning, increases reliance on external funding and dilutive instruments, and limits the company’s ability to invest in growth or absorb market shocks over the medium term.
Declining Revenue And Sustained LossesA TTM revenue decline alongside recurring operating and net losses signals structural demand, pricing, or cost‑structure challenges. Even with improved gross margin, ongoing operating losses erode capital, restrict reinvestment capacity, and make long‑term recovery dependent on revenue stabilization or material cost restructuring.
IM Cannabis Corp News
IMCC FAQ
What was IM Cannabis Corp’s price range in the past 12 months?
IM Cannabis Corp lowest stock price was $0.22 and its highest was $7.12 in the past 12 months.
What is IM Cannabis Corp’s market cap?
IM Cannabis Corp’s market cap is $1.79M.
When is IM Cannabis Corp’s upcoming earnings report date?
IM Cannabis Corp’s upcoming earnings report date is Aug 17, 2026 which is in 77 days.
How were IM Cannabis Corp’s earnings last quarter?
IM Cannabis Corp released its earnings results on May 13, 2026. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.28.
Is IM Cannabis Corp overvalued?
According to Wall Street analysts IM Cannabis Corp’s price is currently Overvalued.
Does IM Cannabis Corp pay dividends?
IM Cannabis Corp does not currently pay dividends.
What is IM Cannabis Corp’s EPS estimate?
IM Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IM Cannabis Corp have?
IM Cannabis Corp has 6,223,323 shares outstanding.
What happened to IM Cannabis Corp’s price movement after its last earnings report?
IM Cannabis Corp reported an EPS of -$0.28 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.187%.
Which hedge fund is a major shareholder of IM Cannabis Corp?
Currently, no hedge funds are holding shares in IMCC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IM Cannabis Corp
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Technical Analysis
Ownership Overview
23.24% Insiders
0.23% Other Institutional Investors
76.53% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---